Bronchial Blockers vs Double-Lumen Tubes in Obese Patients
Recruiting
N/A
Interventional Study
One-lung Ventilation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 46 (estimated)
- Sponsor
- Paulo Andrés Cano Jiménez · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the efficacy of bronchial blockers and double-lumen tubes in achieving one-lung ventilation in obese patients undergoing lung resections. The primary question it aims to answer is:
• Is intraoperative hypoxia significantly different depending on the device used?
Researchers will compare the use of bronchial blockers and double-lumen tubes to assess …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* BMI ≥ 30 kg/m2
* Diagnostic or clinical suspicion of lung cancer
* Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy, requiring one-lung ventilation.
* Use of bronchial blocker or double-lumen tube for one-lung ventilation.
Exclusion …
Contacts